The necessity of diplomacy in brain health

Walter D. Dawson; Kirsten Bobrow; Agustin Ibanez; Laura Booi; Maritza Pintado-Caipa; Stacey Yamamoto; Ioannis Tarnanas; Timothy Evans; Adelina Comas-Herrera; Jeffrey Cummings; Jeffrey Kaye; Kristine Yaffe; Bruce L. Miller; Harris A. Eyre

doi:10.1016/S1474-4422(20)30358-6

The necessity of diplomacy in brain health

Walter D. Dawson, Kirsten Bobrow, Agustin Ibanez, Laura Booi, Maritza Pintado-Caipa, Stacey Yamamoto, Ioannis Tarnanas, Timothy Evans, Adelina Comas-Herrera, Jeffrey Cummings, Jeffrey Kaye, Kristine Yaffe, Bruce L. Miller, Harris A. Eyre

Producción científica: Contribución a una revista › Carta › revisión exhaustiva

19 Citas (Scopus)

Idioma original	Inglés
Páginas (desde-hasta)	972-974
Número de páginas	3
Publicación	The Lancet Neurology
Volumen	19
N.º	12
DOI	https://doi.org/10.1016/S1474-4422(20)30358-6
Estado	Publicada - dic. 2020
Publicado de forma externa	Sí

Acceder al documento

10.1016/S1474-4422(20)30358-6

Citar esto

@article{e5254c9d7f774773b04b7de0d4f68563,

title = "The necessity of diplomacy in brain health",

author = "Dawson, {Walter D.} and Kirsten Bobrow and Agustin Ibanez and Laura Booi and Maritza Pintado-Caipa and Stacey Yamamoto and Ioannis Tarnanas and Timothy Evans and Adelina Comas-Herrera and Jeffrey Cummings and Jeffrey Kaye and Kristine Yaffe and Miller, {Bruce L.} and Eyre, {Harris A.}",

note = "Funding Information: WDD reports personal fees from AARP, Commonwealth Fund, Insights to Illuminate, Cognitive Solutions, Oregon Health Care Association, Splaine Consulting, and Mather, outside the submitted work; AI reports grants from FONCyT-PICT 2017-1818 & 2017-1820, FONDAP 15150012, Interamerican Development Bank (IDB), Alzheimer's Association GBHI ALZ UK-20-639295, and the Multi-Partner Consortium to Expand Dementia Research in Latin America, supported by NIH NIA R01 AG057234, Alzheimer's Association (SG-20-725707), Tau Consortium, and Global Brain Health Institute, outside the submitted work; JC reports grants from NIH–NIGMS, NIH, and NIH–NINDS; personal fees from Keep Memory Alive, during the conduct of the study; personal fees from Acadia, Actinogen, AgeneBio, Alkahest, Alzheon, Annovis, Avanir, Axsome, Biogen, Cassava, Cerecin, Cerevel, Cognoptix, Cortexyme, EIP Pharma, Eisai, Foresight, Green Valley, Grifols, Karuna, Nutricia, Orion, Otsuka, Probiodrug, ReMYND, Resverlogix, Roche, Samumed, Samus Therapeutics, Third Rock, Signant Health, Sunovion, Suven, and United Neuroscience pharmaceutical and assessment companies, and the Alzheimer Drug Discovery Foundation; and other from ADAMAS, BioAsis, MedAvante, QR Pharma, and United Neuroscience, outside the submitted work. In addition, JC has a patent Neuropsychiatric Inventory (NPI) with royalties paid and is the Chief Scientific Advisor of CNS Innovations and a Board member of Keep Memory Alive; KY serves on DSMBs for Eli Lilly and a National Institute on Aging-sponsored study, is a board member of Alector, and is also a member of the Beeson Scientific Advisory Board and the Global Council on Brain Health; HAE reports personal fees from CNSdose, Scioto Biosciences, Prodeo, and Altoida, outside the submitted work; KB, LB, MP-C, SY, IT, AC-H, TE, JK, and BLM declare no competing interests.",

year = "2020",

month = dec,

doi = "10.1016/S1474-4422(20)30358-6",

language = "English",

volume = "19",

pages = "972--974",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd.",

number = "12",

}

TY - JOUR

T1 - The necessity of diplomacy in brain health

AU - Dawson, Walter D.

AU - Bobrow, Kirsten

AU - Ibanez, Agustin

AU - Booi, Laura

AU - Pintado-Caipa, Maritza

AU - Yamamoto, Stacey

AU - Tarnanas, Ioannis

AU - Evans, Timothy

AU - Comas-Herrera, Adelina

AU - Cummings, Jeffrey

AU - Kaye, Jeffrey

AU - Yaffe, Kristine

AU - Miller, Bruce L.

AU - Eyre, Harris A.

N1 - Funding Information: WDD reports personal fees from AARP, Commonwealth Fund, Insights to Illuminate, Cognitive Solutions, Oregon Health Care Association, Splaine Consulting, and Mather, outside the submitted work; AI reports grants from FONCyT-PICT 2017-1818 & 2017-1820, FONDAP 15150012, Interamerican Development Bank (IDB), Alzheimer's Association GBHI ALZ UK-20-639295, and the Multi-Partner Consortium to Expand Dementia Research in Latin America, supported by NIH NIA R01 AG057234, Alzheimer's Association (SG-20-725707), Tau Consortium, and Global Brain Health Institute, outside the submitted work; JC reports grants from NIH–NIGMS, NIH, and NIH–NINDS; personal fees from Keep Memory Alive, during the conduct of the study; personal fees from Acadia, Actinogen, AgeneBio, Alkahest, Alzheon, Annovis, Avanir, Axsome, Biogen, Cassava, Cerecin, Cerevel, Cognoptix, Cortexyme, EIP Pharma, Eisai, Foresight, Green Valley, Grifols, Karuna, Nutricia, Orion, Otsuka, Probiodrug, ReMYND, Resverlogix, Roche, Samumed, Samus Therapeutics, Third Rock, Signant Health, Sunovion, Suven, and United Neuroscience pharmaceutical and assessment companies, and the Alzheimer Drug Discovery Foundation; and other from ADAMAS, BioAsis, MedAvante, QR Pharma, and United Neuroscience, outside the submitted work. In addition, JC has a patent Neuropsychiatric Inventory (NPI) with royalties paid and is the Chief Scientific Advisor of CNS Innovations and a Board member of Keep Memory Alive; KY serves on DSMBs for Eli Lilly and a National Institute on Aging-sponsored study, is a board member of Alector, and is also a member of the Beeson Scientific Advisory Board and the Global Council on Brain Health; HAE reports personal fees from CNSdose, Scioto Biosciences, Prodeo, and Altoida, outside the submitted work; KB, LB, MP-C, SY, IT, AC-H, TE, JK, and BLM declare no competing interests.

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85096223869&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(20)30358-6

DO - 10.1016/S1474-4422(20)30358-6

M3 - Letter

C2 - 33212057

AN - SCOPUS:85096223869

SN - 1474-4422

VL - 19

SP - 972

EP - 974

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 12

ER -